Evidence map›Paper›PMID 40966293›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

C4d, a high-affinity LilrB2 ligand, is elevated in Alzheimer's disease and mediates synapse pruning.

Barbara K Brott, Aram J Raissi, Kristina D Micheva, Jost Vielmetter, Monique S Mendes, Caroline J Baccus, Jolie Huang, Carla J Shatz

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Barbara K Brott *Departments of Biology and Neurobiology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305.
Aram J Raissi *Departments of Biology and Neurobiology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305.
Kristina D MichevaDepartment of Molecular and Cellular Physiology, Stanford University, Stanford, CA 94305.
Jost VielmetterDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125.ORCID 0000-0002-4314-7163
Monique S MendesDepartments of Biology and Neurobiology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305.
Caroline J BaccusDepartments of Biology and Neurobiology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305.
Jolie HuangDepartments of Biology and Neurobiology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305.
Carla J ShatzDepartments of Biology and Neurobiology and Bio-X, James H. Clark Center, Stanford University, Stanford, CA 94305.ORCID 0000-0001-5432-5917

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
FETAL AND POSTNATAL DEVELOPMENT OF VISUAL CONNECTIONSR01EY002858 · NEI · STANFORD UNIVERSITY · PI SHATZ, CARLA J · 1985 to 2020
$9.9M
Innate immune signaling at the synapse in development and pathological Alzheimer’s diseaseR01AG065206 · NIA · STANFORD UNIVERSITY · PI SHATZ, CARLA J · 2020 to 2024
$2.0M
FETAL AND POSTNATAL DEVELOPMENT OF VISUAL CONNECTIONSR37EY002858 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI SHATZ, CARLA J · 1992 to 2001
$689k
Determining cell-type specificity for a nonclassical MHC class I during an activity-dependent cortical critical period.R21EY033924 · NEI · STANFORD UNIVERSITY · PI SHATZ, CARLA J · 2022 to 2023
$471k
Fundação Champalimaud (CF) N/AG. Harold and Leila Y. Mathers Foundation (Mathers Foundation) N/AHHS | NIH | National Eye Institute (NEI) EY02858HHS | NIH | National Institute on Aging (NIA) AG065206NEI NIH HHS R01 EY002858NEI NIH HHS R21 EY033924NEI NIH HHS R37 EY002858NIA NIH HHS P01 AG019724NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG065206NINDS NIH HHS L70 NS134082
6 · The paper itself

Abstract

Synapse pruning sculpts neural circuits throughout life. The human Leukocyte immunoglobulin-like receptor type B2 (LilrB2)/murine Paired immunoglobulin receptor B (PirB) receptors expressed in neurons and complement protein C4 have been separately implicated in pruning. Here, we report that C4d, a C4 cleavage product with unknown function, binds LilrB2/PirB with nanomolar affinity. C4d and LilrB2 colocalize at excitatory synapses in the human cerebral cortex as well as with beta amyloid in Alzheimer's disease (AD). C4d, as well as C4, increase with age and more so in AD. To examine whether C4d-PirB interactions can drive pruning, dendritic spines-the postsynaptic structure of excitatory synapses-were monitored on L5 pyramidal neurons in the mouse cerebral cortex: A significant decrease in dendritic spine density occurred in WT with C4d exposure, but KO of PirB completely prevented this loss. Together, our findings reveal an unexpected physiological role for C4d in pruning and imply that different complement cascade components may collaborate to engage both neuronal and glial-specific effectors of synaptic pruning.

Indexed as

Alzheimer DiseaseComplement C4Complement C4bMembrane GlycoproteinsReceptors, ImmunologicSynapsesAgedAmyloid beta-PeptidesAnimalsCerebral CortexDendritic SpinesFemaleHumansLigandsMaleMiceAmyloid beta-PeptidesComplement C4Complement C4bLigandsLILRB2 protein, humanMembrane GlycoproteinsPirb protein, mouseReceptors, ImmunologicAlzheimer’s diseasecomplement component C4dhuman cerebral cortexneuronal pruning receptorssynapse pruning

Identifiers

PMID40966293
PMCPMC12478167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.